Skip to the page

Data / Form D filings / Provell Pharmaceuticals, LLC

Provell Pharmaceuticals, LLC: Form D filings

Provell Pharmaceuticals, LLC, a pharmaceuticals company in Honey Brook, PA, filed 6 Form D notices with the SEC between 2013 and 2024. The latest, on February 14, 2024, reports $600,000 sold of a $600,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1801 HORESHOE PIKE, Honey Brook, PA, 19341
Phone
(610) 942-9455
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Pennsylvania
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1592082

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 14, 2024New notice$600,000$600,0001Jan 31, 2024sec.gov
Aug 15, 2023New notice$1,000,000$1,000,0001Aug 1, 2023sec.gov
Mar 28, 2023New notice$2,000,000$2,000,0001Mar 15, 2023sec.gov
Jul 11, 2022New notice$2,000,000$2,000,0001Jun 29, 2022sec.gov
Jul 10, 2019New notice$2,000,000$2,000,0001Jun 25, 2019sec.gov
Dec 3, 2013New notice$5,000,000$5,000,0001Oct 3, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James G. SmallExecutive Officer

Other pharmaceuticals companies in Pennsylvania that filed recently

Every Form D from the week of Feb 12, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Provell Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.